Clinical Trial

Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN

Name: Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPN — clinical trial record (NCT07710534)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a single-center randomized phase 2 open-label clinical trial.

Trial Details

NCT Number	NCT07710534
Lead Sponsor	Virginia Commonwealth University
Conditions	Relapsed / Refractory AML, High Risk Myelodysplastic Syndrome, High Risk Myeloproliferative Neoplasms
Enrollment	40 participants
Start Date	2026-09-30
Primary Completion	2031-09-30 (estimated)
Study Completion	2033-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-17